bromodeoxyuridine has been researched along with Precancerous Conditions in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (5.17) | 18.7374 |
1990's | 31 (53.45) | 18.2507 |
2000's | 22 (37.93) | 29.6817 |
2010's | 2 (3.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arihara, K; Asano, T; Ishikawa, S; Itoh, M; Nozawa, Y; Takenoshita, S | 1 |
Ahr, HJ; Dietrich, DR; Ellinger-Ziegelbauer, H; Stemmer, K | 1 |
Behbod, F; Boulanger, CA; Bussard, KM; Kittrell, FS; Medina, D; Smith, GH | 1 |
Chen, XF; Ge, LH; Miao, CC; Sun, Z; Tian, ZC; Zhang, XY | 1 |
Barbisan, LF; da Eira, AF; de Camargo, JL; Moreira, EL; Ribeiro, LR; Salvadori, DM; Spinardi-Barbisan, AL | 1 |
Hirose, Y; Katayama, M; Kohno, H; Kuno, T; Mori, H; Qiao, Z; Sakata, K; Shibata, T; Sugie, S; Tanaka, T; Yamada, Y; Yoshida, K | 1 |
D'Ambrosio, SM; Ding, H; Gibson-D'Ambrosio, R; Han, C; Steele, VE | 1 |
Doi, K; Fukushima, S; Mitsuhashi, M; Moku, M; Morimura, K; Salim, EI; Shen, J; Wanibuchi, H; Wei, M | 1 |
Bierkamp, C; Clerc, P; Dufresne, M; Fourmy, D; Lulka, H; Mathieu, A; Portolan, G; Pradayrol, L; Seva, C | 1 |
Fukami, H; Hirata, A; Sakai, H; Tatematsu, M; Tsukamoto, T | 1 |
Fukushima, S; Kashimoto, N; Kyo, E; Sumi, S; Sumioka, I; Uda, N | 1 |
Hatakeyama, D; Kato, K; Long, NK; Makita, H; Shibata, T; Toida, M; Yamashita, T | 1 |
Hara, A; Makita, H; Mori, H; Ohnishi, M; Satoh, K; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J | 1 |
Chong, W; Hua, H; Wei, K | 1 |
Hara, A; Makita, H; Mori, H; Ohnishi, M; Satoh, K; Tanaka, T | 1 |
Kawamori, T; Mori, H; Okamoto, K; Suzui, M; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J | 1 |
Fennerty, B; Garewal, HS; Ramsey, L; Sampliner, R | 1 |
Bird, RP; Sutherland, LA | 1 |
Esumi, H; Minamoto, T; Onda, M; Yamashita, N | 1 |
Bird, RP; Magnuson, BA; Shirtliff, N | 1 |
Itoh, T; Takahashi, H; Yamamoto, Y | 1 |
Ito, Y | 1 |
Cass, L; Dubin, JA; Fujita, K; Glober, GA; Hittelman, WN; Konishi, H; Lee, JJ; Spaulding, D; Steinbach, G; Terry, NH | 1 |
Hara, A; Kawamori, T; Koshimizu, K; Makita, H; Mori, H; Murakami, A; Ohigashi, H; Ohnishi, M; Satoh, K; Tanaka, T | 1 |
Fujitsuka, H; Hara, A; Makita, H; Mori, H; Satoh, K; Tanaka, T; Tatematsu, N | 1 |
Fukutani, K; Hara, A; Kakumoto, M; Kawabata, K; Makita, H; Mori, H; Ogawa, H; Satoh, K; Sumida, T; Tanaka, T | 1 |
Everitt, JI; Goldsworthy, TW; Walker, CL; Wolf, DC | 1 |
Goto, K; Inada, K; Kobayashi, K; Mutai, M; Nakanishi, H; Tatematsu, M; Tsukamoto, T | 1 |
Akai, H; Andoh, N; Denda, A; Horiguchi, K; Kobayashi, Y; Konishi, Y; Nakae, D; Satoh, H; Tamura, K; Tsujiuchi, T; Yoshiji, H | 1 |
Deguchi, T; Hirose, Y; Kawada, Y; Mori, H; Tanaka, T; Yang, M | 1 |
Furusaka, A; Hiramoto, J; Hiyane, S; Nagayama, K; Nakada, T; Ogasawara, H; Shirahama, K; Takahashi, M; Tanaka, T | 1 |
Hara, A; Kakumoto, M; Kawabata, K; Koshimizu, K; Kuki, W; Maeda, M; Matsunaga, K; Mori, H; Murakami, A; Odashima, S; Ohigashi, H; Ota, T; Satoh, K; Takahashi, Y; Tanaka, T; Yonei, H | 1 |
Dohi, K; Ito, A; Katoh, O; Masaoka, Y; Watanabe, H | 1 |
Archer, MC; Sarma, DS; Wood, GA | 1 |
Benjamin, SA; Brown, MD; Chubb, LW; Dean, CE; Keefe, TJ; Tessari, JD; Yang, RS | 1 |
Ganther, HE; Ip, C; Thompson, HJ | 1 |
Given, R; Singh, P; Varro, A; Velasco, M; Wang, TC; Wargovich, M | 1 |
Felix, DH; MacDonald, DG; Oliver, RJ | 1 |
Bock, KW; Bock-Hennig, BS; Eriksson, LC; Gschaidmeier, H | 1 |
Asamoto, M; Futakuchi, M; Hagiwara, A; Imaida, K; Ogawa, K; Sano, M; Shirai, T; Tamano, S; Yoshino, H | 1 |
Fujii, K; Ito, Y; Kawabata, K; Mori, H; Pham, QV; Sugie, S; Takeuchi, H; Tanaka, T; Ushida, J | 1 |
MacDonald, DG; Oliver, RJ | 1 |
Archer, MC; Korkola, JE; Wood, GA | 1 |
Fukushima, S; Iwai, S; Morimura, K; Nomura, T; Takayama, R; Wanibuchi, H; Wei, M; Yamamoto, S | 1 |
Dashwood, RH; Exon, JH; Hendrix, K; Hubele, S; Magnuson, BA; South, EH; Xu, M | 1 |
Adams, TE; Bhathal, PS; Snibson, KJ | 1 |
Han, BS; Naito, A; Nomura, E; Park, CB; Sekine, K; Takasuka, N; Taniguchi, H; Tsuda, H; Tsuno, T | 1 |
Deguchi, T; Hara, A; Katayama, M; Mori, H; Sugie, S; Tanaka, T; Vinh, PQ; Yamada, Y | 1 |
Banerjee, MR; Bodell, WJ | 1 |
Aoki, T; Hakoi, K; Ito, N; Kato, T; Ozaki, K; Sato, K; Tsuda, H; Uwagawa, S; Yamaguchi, S | 1 |
Rozen, P | 1 |
Barbara, L; Biasco, G; Miglioli, M; Paganelli, GM | 1 |
Hasegawa, R; Hirose, M; Hoshiya, T; Ito, N; Shirai, T; Takaba, K; Tiwawech, D | 1 |
Fujita, S; Fukuda, M; Hattori, T; Imamura, Y; Katsura, K; Noriki, S; Sugihara, H; Tsuchihashi, Y | 1 |
Xie, YJ | 1 |
Fujisawa, M; Hashimoto, H; Kaneko, S; Sasaki, M; Tokunaka, S; Yachiku, S | 1 |
Cameron, RG | 1 |
Göhde, W; Mauro, F; Schumann, J; Teodori, L | 1 |
2 review(s) available for bromodeoxyuridine and Precancerous Conditions
Article | Year |
---|---|
An evaluation of rectal epithelial proliferation measurement as biomarker of risk for colorectal neoplasia and response in intervention studies.
Topics: Biomarkers; Biopsy; Bromodeoxyuridine; Colitis, Ulcerative; Colorectal Neoplasms; Confounding Factors, Epidemiologic; Humans; Hyperplasia; Immunohistochemistry; Precancerous Conditions; Predictive Value of Tests; Rectum; Risk Factors; Sigmoidoscopy | 1992 |
Cell proliferation biomarkers in the gastrointestinal tract.
Topics: Animals; Biomarkers; Biomarkers, Tumor; Bromodeoxyuridine; Cell Cycle; Cell Division; Digestive System; Gastric Mucosa; Gastrointestinal Neoplasms; Histological Techniques; Humans; Intestinal Mucosa; Kinetics; Precancerous Conditions | 1992 |
56 other study(ies) available for bromodeoxyuridine and Precancerous Conditions
Article | Year |
---|---|
Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Bromodeoxyuridine; Carcinogens; Caseins; Cecum; Cell Proliferation; Colon; Colonic Neoplasms; DNA; Egg Proteins; Fatty Acids, Volatile; Intestinal Mucosa; Male; Precancerous Conditions; Rats; Rats, Inbred F344 | 2009 |
Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors.
Topics: Animals; Apoptosis; Aristolochic Acids; Bromodeoxyuridine; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Kidney Neoplasms; Kidney Tubules; Models, Biological; Ochratoxins; Precancerous Conditions; Rats; Staining and Labeling; Trans-Activators; Transcription Factors | 2009 |
Immortalized, pre-malignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA.
Topics: Animals; Asymmetric Cell Division; Autoradiography; Bromodeoxyuridine; DNA; DNA Replication; Epithelial Cells; Estrogen Receptor alpha; Female; Mammary Glands, Animal; Mice; Mice, Inbred BALB C; Precancerous Conditions; Pregnancy; Receptors, Progesterone; Stem Cells; Templates, Genetic; Thymidine; Tritium | 2010 |
[Chemopreventive effect of boswellic acid and curcumin on 7,12-dimethyl benzanthracene-induced hamster cheek pouch carcinogenesis].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogenesis; Carcinogens; Carcinoma, Squamous Cell; Cheek; Cricetinae; Curcumin; Hyperplasia; Leukotriene B4; Male; Mesocricetus; Mouth Neoplasms; Precancerous Conditions; Random Allocation; Triterpenes | 2011 |
Agaricus blazei (Himematsutake) does not alter the development of rat diethylnitrosamine-initiated hepatic preneoplastic foci.
Topics: Agaricus; Animals; Anticarcinogenic Agents; Apoptosis; Biomarkers, Tumor; Brazil; Bromodeoxyuridine; Cell Division; Chemical and Drug Induced Liver Injury; Diethylnitrosamine; DNA Replication; Drug Screening Assays, Antitumor; Glutathione Transferase; Hepatocytes; Liver Diseases; Liver Neoplasms, Experimental; Male; Medicine, Traditional; Neoplasm Proteins; Organ Size; Phytotherapy; Plant Extracts; Precancerous Conditions; Rats; Rats, Wistar; Water | 2003 |
Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogens; Chromans; Cyclin D1; Cyclooxygenase 2; DNA-Binding Proteins; Incidence; Isoenzymes; Ligands; Male; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Tongue; Tongue Neoplasms; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2003 |
Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1.
Topics: Base Sequence; Bromodeoxyuridine; Cell Division; Cell Line; Cell Survival; Cyclooxygenase Inhibitors; Dinoprostone; DNA Primers; Humans; Mouth Mucosa; Mouth Neoplasms; Piroxicam; Polymerase Chain Reaction; Precancerous Conditions; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2003 |
Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Animals; Benzenesulfonates; Bromodeoxyuridine; Carcinogens; Cell Division; Colon; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Isoenzymes; Male; Oxazoles; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344 | 2003 |
Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation.
Topics: Adenoma; Animals; Antimetabolites, Antineoplastic; Azaserine; Bromodeoxyuridine; Carcinogens; Carcinoma, Acinar Cell; Cell Proliferation; Coloring Agents; Homeodomain Proteins; Homozygote; Immunohistochemistry; Inflammation; Lymphocytes; Mice; Mice, Transgenic; Pancreatic Neoplasms; Phenotype; Precancerous Conditions; Receptor, Cholecystokinin B; Receptors, G-Protein-Coupled; Risk; Time Factors; Trans-Activators; Transgenes | 2005 |
Three-dimensional analysis of isolated hexosaminidase-altered aberrant crypts from colons of 1,2-dimethylhydrazine-treated rats.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; beta-N-Acetylhexosaminidases; Biomarkers, Tumor; Bromodeoxyuridine; Colon; Colonic Neoplasms; Intestinal Mucosa; Male; Microscopy, Electron, Scanning; Precancerous Conditions; Rats; Rats, Inbred F344 | 2006 |
Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis.
Topics: Animals; Body Weight; Bromodeoxyuridine; Carcinogens; Dimethylhydrazines; Feeding Behavior; Garlic; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mitotic Index; Phytotherapy; Plant Extracts; Precancerous Conditions; Rats; Rats, Inbred F344 | 2006 |
Chemopreventive effect of fermented brown rice and rice bran on 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats.
Topics: Animals; Bromodeoxyuridine; Cell Transformation, Neoplastic; Cyclic N-Oxides; Dietary Fiber; Male; Mouth Neoplasms; Oryza; Precancerous Conditions; Rats; Rats, Inbred F344 | 2007 |
Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases.
Topics: 4-Butyrolactone; 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Biogenic Polyamines; Bromodeoxyuridine; Carcinogens; Cell Division; Male; Mouth Neoplasms; Nuclear Proteins; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Retinoids; Silver Staining | 1995 |
[Cell kinetics of experimental premalignant lesions of the oral mucosa by Brdu labelling].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bromodeoxyuridine; Cricetinae; DNA, Neoplasm; Immunoenzyme Techniques; Male; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions | 1995 |
Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin.
Topics: Animals; Anticarcinogenic Agents; beta Carotene; Bromodeoxyuridine; Canthaxanthin; Carotenoids; Male; Mouth Neoplasms; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Xanthophylls | 1995 |
Chemoprevention of azoxymethane-induced intestinal carcinogenesis by a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone, in rats.
Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Azoxymethane; Biomarkers, Tumor; Bromodeoxyuridine; Colon; Dose-Response Relationship, Drug; Epithelium; Intestinal Neoplasms; Male; Ornithine Decarboxylase; Precancerous Conditions; Rats; Rats, Inbred F344; Retinoids | 1995 |
Demonstration of a field defect in gastric intestinal metaplasia by biological marker analysis.
Topics: Aged; Biomarkers, Tumor; Biopsy; Bromodeoxyuridine; Female; Humans; Intestines; Male; Metaplasia; Middle Aged; Ornithine Decarboxylase; Precancerous Conditions; Prospective Studies; Pyloric Antrum; S Phase; Stomach | 1994 |
The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon.
Topics: Animals; Antigens, Neoplasm; Body Weight; Bromodeoxyuridine; Cell Division; Chenodeoxycholic Acid; Colon; Colonic Neoplasms; Dose-Response Relationship, Drug; Eating; Male; Nuclear Proteins; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley | 1994 |
Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.
Topics: Animals; Azoxymethane; Bromodeoxyuridine; Cell Division; Colon; Colonic Neoplasms; Epithelium; Kinetics; Male; Mitotic Index; Nuclear Proteins; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344 | 1994 |
Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid.
Topics: Animals; Apoptosis; Azoxymethane; Bromodeoxyuridine; Cholic Acid; Cholic Acids; Colonic Neoplasms; DNA; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley | 1994 |
Assessment of bromodeoxyuridine-labeled S-phase cells in experimentally induced precancerous lesions in the rat's tongue.
Topics: 4-Nitroquinoline-1-oxide; Animals; Bromodeoxyuridine; Carcinoma in Situ; Carcinoma, Squamous Cell; Cell Count; Cell Division; Epithelium; Hyperplasia; Leukoplakia, Oral; Male; Neoplasm Invasiveness; Papilloma; Precancerous Conditions; Rats; Rats, Sprague-Dawley; S Phase; Tongue Neoplasms | 1994 |
[DNA synthesis of the mucosa of the gallbladder estimated by bromodeoxyuridine (BrdU)-anti BrdU in vitro method in patients with various gallbladder disorders].
Topics: Aged; Antibodies, Monoclonal; Bromodeoxyuridine; DNA; Female; Gallbladder Diseases; Gallbladder Neoplasms; Humans; Male; Middle Aged; Mucous Membrane; Precancerous Conditions | 1993 |
Histone H3 messenger RNA in situ hybridization correlates with in vivo bromodeoxyuridine labeling of S-phase cells in rat colonic epithelium.
Topics: Animals; Biomarkers; Bromodeoxyuridine; Cell Division; Colon; Colonic Neoplasms; Disease Models, Animal; Epithelial Cells; Epithelium; Histones; In Situ Hybridization; Intestinal Mucosa; Male; Mice; Precancerous Conditions; Rats; Rats, Inbred F344; Reproducibility of Results; RNA, Messenger; S Phase; Starvation | 1996 |
Chemopreventive effect of a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate, on rat oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Benzyl Alcohols; Biogenic Polyamines; Bromodeoxyuridine; Carcinogens; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mouth Mucosa; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Silver Staining; Terpenes; Tongue; Tongue Neoplasms; Xanthine Oxidase | 1996 |
Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Biogenic Polyamines; Body Weight; Bromodeoxyuridine; Chalcone; Chalcones; Male; Mouth Neoplasms; Precancerous Conditions; Quercetin; Rats; Rats, Inbred F344 | 1996 |
Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Carcinogens; Diet; Diosmin; Esophageal Neoplasms; Hesperidin; Incidence; Male; Nitrosamines; Nucleolus Organizer Region; Polyamines; Precancerous Conditions; Rats; Rats, Wistar | 1997 |
Altered expression of transforming growth factor-alpha: an early event in renal cell carcinoma development.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Renal Cell; Cell Division; Epithelial Cells; Epithelium; Kidney Neoplasms; Kidney Tubules; Phenotype; Precancerous Conditions; Rats; Rats, Inbred Strains; Transforming Growth Factor alpha | 1997 |
Effects of carbon tetrachloride administration on initiation of liver cell foci by the non-hepatocarcinogens N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and benzo(a)pyrene (B(a)P).
Topics: Animals; Benzo(a)pyrene; Biomarkers, Tumor; Bromodeoxyuridine; Carbon Tetrachloride; Cell Division; Glutathione Transferase; Hepatectomy; Liver Neoplasms; Liver Regeneration; Male; Methylnitronitrosoguanidine; Mitotic Index; Precancerous Conditions; Rats; Rats, Inbred F344 | 1997 |
Inhibition by N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid of exogenous and endogenous development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in the livers of rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Choline Deficiency; Deoxyguanosine; Fenretinide; Glutathione Transferase; Liver; Liver Neoplasms, Experimental; Male; Placenta; Precancerous Conditions; Rats; Rats, Inbred F344; Tretinoin | 1997 |
Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Diosmin; DNA, Neoplasm; Drug Combinations; Hesperidin; Male; Mice; Mice, Inbred ICR; Nucleolus Organizer Region; Precancerous Conditions; Silver Staining; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1997 |
Hepatocyte growth factor stimulates DNA synthesis in rat preneoplastic hepatocytes but not in liver carcinoma cells.
Topics: Animals; Bromodeoxyuridine; DNA; Hepatocyte Growth Factor; Humans; Immunohistochemistry; Liver Neoplasms, Experimental; Male; Methyldimethylaminoazobenzene; Phosphorylation; Precancerous Conditions; Proto-Oncogene Proteins c-met; Rats; Type C Phospholipases; Tyrosine | 1998 |
Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats.
Topics: 4-Nitroquinoline-1-oxide; Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Carcinogens; Coumarins; Glutathione Transferase; Liver; Male; Mouth Mucosa; NAD(P)H Dehydrogenase (Quinone); Pilot Projects; Polyamines; Precancerous Conditions; Rats; Rats, Inbred F344; Tongue Neoplasms | 1998 |
Effects of miso and NaCl on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Topics: Animals; Body Weight; Bromodeoxyuridine; Colonic Neoplasms; Edible Grain; Fermentation; Male; Organ Size; Precancerous Conditions; Rats; Rats, Inbred F344; Sodium Chloride | 1998 |
Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats.
Topics: 2-Acetylaminofluorene; Animals; Apoptosis; Bromodeoxyuridine; Cell Division; Diethylnitrosamine; Glutathione Transferase; Hepatectomy; Liver Neoplasms, Experimental; Male; Precancerous Conditions; Rats; Rats, Inbred F344; Rats, Inbred Strains; Species Specificity; Time Factors | 1999 |
Lack of promotional effects of groundwater contaminant mixtures on the induction of preneoplastic foci in rat liver.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Biological Assay; Body Weight; Bromodeoxyuridine; Cell Division; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Precancerous Conditions; Rats; Rats, Inbred F344; Water Pollutants; Water Supply | 1999 |
Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
Topics: Animals; Anticarcinogenic Agents; Antimetabolites; Antineoplastic Agents; Biomarkers; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Transformation, Neoplastic; Chemoprevention; Coloring Agents; Cyclin D; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Cysteine; Enzyme Inhibitors; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Microtubule-Associated Proteins; Organoselenium Compounds; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Selenocysteine; Tumor Suppressor Proteins | 2000 |
Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM.
Topics: Animals; Azoxymethane; Bromodeoxyuridine; Carcinogens; Colon; Colonic Neoplasms; Disease Susceptibility; Gastrins; Humans; Mice; Mice, Inbred Strains; Mice, Transgenic; Precancerous Conditions; Protein Precursors | 2000 |
Aspects of cell proliferation in oral epithelial dysplastic lesions.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Basement Membrane; Biomarkers, Tumor; Bromodeoxyuridine; Cell Division; Cell Nucleus; Cell Transformation, Neoplastic; Epithelial Cells; Female; Forecasting; Humans; Hyperplasia; Ki-67 Antigen; Leukoplakia, Oral; Male; Middle Aged; Mouth Floor; Mouth Mucosa; Mouth Neoplasms; Precancerous Conditions; Reproducibility of Results; Tongue Neoplasms | 2000 |
Density-dependent growth of normal and nodular hepatocytes.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cells, Cultured; DNA; Epidermal Growth Factor; Liver; Male; Mitogens; Polychlorinated Dibenzodioxins; Precancerous Conditions; Rats; Rats, Wistar; Thymidine | 2000 |
Inhibitory effects of low doses of melatonin on induction of preneoplastic liver lesions in a medium-term liver bioassay in F344 rats: relation to the influence of electromagnetic near field exposure.
Topics: Adrenocorticotropic Hormone; Alkylating Agents; Animals; Biological Assay; Body Weight; Bromodeoxyuridine; Corticosterone; Diethylnitrosamine; Dose-Response Relationship, Drug; Electromagnetic Fields; Follicle Stimulating Hormone; Glutathione Transferase; Liver; Liver Neoplasms; Luteinizing Hormone; Male; Melatonin; Precancerous Conditions; Rats; Rats, Inbred F344; Testosterone; Time Factors | 2000 |
Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats.
Topics: Animals; Anticarcinogenic Agents; Bromodeoxyuridine; Carcinogens; Curcumin; Dimethylnitrosamine; Esophageal Neoplasms; Male; Precancerous Conditions; Rats; Rats, Inbred F344 | 2000 |
Comparison of BrdU and cyclin A as markers of the S-phase in oral precancerous lesions.
Topics: Adult; Aged; Biomarkers, Tumor; Biopsy; Bromodeoxyuridine; Cell Transformation, Neoplastic; Cyclin A; Erythroplasia; Female; Formaldehyde; Humans; Immunohistochemistry; Ki-67 Antigen; Leukoplakia, Oral; Male; Middle Aged; Mouth Floor; Mouth Neoplasms; Precancerous Conditions; S Phase; Statistics, Nonparametric; Tissue Fixation; Tongue Neoplasms | 2000 |
Cyclin D1 expression during rat mammary tumor development and its potential role in the resistance of the Copenhagen rat.
Topics: Animals; Bromodeoxyuridine; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Female; Immunohistochemistry; Mammary Neoplasms, Experimental; Methylnitrosourea; Precancerous Conditions; Rats; Rats, Inbred WF | 1999 |
Chemopreventive effects of S-methylcysteine on rat hepatocarcinogenesis induced by concurrent administration of sodium nitrite and morpholine.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Bromodeoxyuridine; Carcinogens; Cell Division; Cysteine; Drug Interactions; Food Preservatives; Gastric Mucosa; Glutathione Transferase; Liver; Liver Neoplasms, Experimental; Male; Morpholines; Nitrosamines; Precancerous Conditions; Rats; Rats, Inbred F344; Sodium Nitrite | 2000 |
Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci.
Topics: Age Factors; Animals; Azoxymethane; beta Catenin; Bromodeoxyuridine; Carcinogens; Cecum; Cell Division; Colon; Colonic Diseases; Cytoskeletal Proteins; Disease Susceptibility; Female; Immunohistochemistry; Mutation; Polymorphism, Single-Stranded Conformational; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Rectum; Sodium Chloride; Time Factors; Trans-Activators | 2000 |
Overexpressed growth hormone (GH) synergistically promotes carcinogen-initiated liver tumour growth by promoting cellular proliferation in emerging hepatocellular neoplasms in female and male GH-transgenic mice.
Topics: Animals; Animals, Newborn; Apoptosis; Bromodeoxyuridine; Cell Division; Diethylnitrosamine; Female; Focal Nodular Hyperplasia; Growth Hormone; Image Processing, Computer-Assisted; Immunoenzyme Techniques; In Situ Nick-End Labeling; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organ Size; Precancerous Conditions; Time Factors | 2001 |
A ferulic acid derivative, ethyl 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Bromodeoxyuridine; Cell Division; Colon; Colonic Neoplasms; Coumaric Acids; Eating; Kidney; Liver; Male; Organ Size; Precancerous Conditions; Rats; Rats, Inbred F344; Terpenes | 2001 |
Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Antioxidants; Bromodeoxyuridine; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cell Cycle; Cyclin D1; Male; Mice; Mice, Inbred ICR; Papilloma; Precancerous Conditions; Silymarin; Urinary Bladder Neoplasms | 2002 |
DNA repair in normal and preneoplastic mammary tissues.
Topics: Animals; Bromodeoxyuridine; DNA Repair; DNA Replication; DNA, Neoplasm; Female; Hydroxyurea; In Vitro Techniques; Mammary Neoplasms, Experimental; Methyl Methanesulfonate; Mice; Mice, Inbred BALB C; Precancerous Conditions; Pregnancy; Thymidine | 1978 |
Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats.
Topics: Adenosine Triphosphatases; Animals; Bromodeoxyuridine; Cell Division; Clofibrate; Diethylhexyl Phthalate; Diethylnitrosamine; Ethoxyquin; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Glutathione Transferase; Isoenzymes; Liver Neoplasms, Experimental; Male; Phenobarbital; Phenotype; Precancerous Conditions; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1992 |
Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses.
Topics: Animals; Antioxidants; Benzodioxoles; Body Weight; Bromodeoxyuridine; Butylated Hydroxyanisole; Catechols; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Synergism; Glutathione Transferase; Hydroquinones; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Phenols; Precancerous Conditions; Rats; Rats, Inbred F344 | 1992 |
Morphology and modes of cell proliferation in earliest signet-ring-cell carcinomas induced in canine stomachs by N-ethyl-N'-nitro-N-nitrosoguanidine.
Topics: Adenocarcinoma, Mucinous; Alcian Blue; Animals; Bromodeoxyuridine; Cell Division; Dogs; Gastric Mucosa; Immunoenzyme Techniques; Methylnitronitrosoguanidine; Precancerous Conditions; Stomach Neoplasms | 1991 |
[Immunohistochemical observation on the proliferative activity of rat liver in early hepatocarcinogenesis].
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Diethylnitrosamine; Female; Hyperplasia; Immunohistochemistry; Liver; Liver Neoplasms, Experimental; Male; Precancerous Conditions; Rats; Rats, Inbred Strains | 1991 |
[The changes of population and distribution of S-phase cells in precancerous lesions of rat bladder revealed by the method of bromodeoxyuridine labeling].
Topics: Animals; Bromodeoxyuridine; Cell Transformation, Neoplastic; Histocytochemistry; Precancerous Conditions; Rats; Rats, Inbred Strains; S Phase; Urinary Bladder Neoplasms | 1990 |
Identification of the putative first cellular step of chemical hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Benzo(a)pyrene; Biomarkers, Tumor; Bromodeoxyuridine; Cell Division; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Resistance; Glutathione Transferase; Hepatectomy; Immunoenzyme Techniques; Liver Neoplasms, Experimental; Liver Regeneration; Male; Precancerous Conditions; Rats; Rats, Inbred F344 | 1989 |
Flow cytometry as a tool for the prognostic assessment of human neoplasia.
Topics: Aneuploidy; Bromodeoxyuridine; Diploidy; DNA, Neoplasm; Flow Cytometry; Humans; Interphase; Neoplasms; Precancerous Conditions | 1986 |